Natural History of the Hymenoptera Venom Sensitivity Reactions in Adults: Study Design.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
04 04 2022
Historique:
received: 11 01 2022
revised: 31 03 2022
accepted: 02 04 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

Allergic reactions to Hymenoptera stings can have varying levels of severity, according to the Müller grading system. By an epidemiological concept, this is a retrospective cohort study. The observed cohort was represented by patients referred to the University Clinic Golnik due to Hymenoptera allergic reaction in the period from 1997 to 2015. From the immunological database of the University Clinic Golnik, we obtained laboratory data (sIgE, skin tests and basophil activation test). The clinical characteristics of patients were obtained from BIRPIS. With the help of a questionnaire, which was sent to each patient in the period from May 2019 to April 2021, we obtained epidemiological data. For the assessment of the association between the severity of allergic reaction for the observed outcome, the severity of the first allergic reaction after Hymenoptera sting was used. Other variables were grouped according to risk factors. We will identify the risk factors that could play an important role in a severe systemic reaction: the aetiology of the Hymenoptera sting, sex, age, history and severity of previous systemic reactions, being re-stung in an interval of two months, the frequency of re-stings, atopy, genetic predisposition, preventive medication use, other medication use, beekeeping or living next to beehives and why immunotherapy was not taken. Laboratory data will also be analysed to determine if there is any association with laboratory tests and the severity of the allergic reactions after Hymenoptera stings. Several new approaches are introduced in the study design. The most important is that the protocol covers epidemiological data gained from the questionnaire, as well as clinical data gained from the Immunological database and BIRPIS database. We expect to obtain significant results that will explain the risk factors for the natural history of Hymenoptera sting allergic reactions and will help allergologists, as well as general doctors, when facing those patients allergic to Hymenoptera venom without immunotherapy.

Sections du résumé

BACKGROUND
Allergic reactions to Hymenoptera stings can have varying levels of severity, according to the Müller grading system.
METHODS
By an epidemiological concept, this is a retrospective cohort study. The observed cohort was represented by patients referred to the University Clinic Golnik due to Hymenoptera allergic reaction in the period from 1997 to 2015. From the immunological database of the University Clinic Golnik, we obtained laboratory data (sIgE, skin tests and basophil activation test). The clinical characteristics of patients were obtained from BIRPIS. With the help of a questionnaire, which was sent to each patient in the period from May 2019 to April 2021, we obtained epidemiological data. For the assessment of the association between the severity of allergic reaction for the observed outcome, the severity of the first allergic reaction after Hymenoptera sting was used. Other variables were grouped according to risk factors.
DISCUSSION
We will identify the risk factors that could play an important role in a severe systemic reaction: the aetiology of the Hymenoptera sting, sex, age, history and severity of previous systemic reactions, being re-stung in an interval of two months, the frequency of re-stings, atopy, genetic predisposition, preventive medication use, other medication use, beekeeping or living next to beehives and why immunotherapy was not taken. Laboratory data will also be analysed to determine if there is any association with laboratory tests and the severity of the allergic reactions after Hymenoptera stings.
CONCLUSIONS
Several new approaches are introduced in the study design. The most important is that the protocol covers epidemiological data gained from the questionnaire, as well as clinical data gained from the Immunological database and BIRPIS database. We expect to obtain significant results that will explain the risk factors for the natural history of Hymenoptera sting allergic reactions and will help allergologists, as well as general doctors, when facing those patients allergic to Hymenoptera venom without immunotherapy.

Identifiants

pubmed: 35409999
pii: ijerph19074319
doi: 10.3390/ijerph19074319
pmc: PMC8998790
pii:
doi:

Substances chimiques

Arthropod Venoms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Ann Allergy Asthma Immunol. 2011 Feb;106(2):159-63
pubmed: 21277518
J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):760-6
pubmed: 9438483
Ann Allergy Asthma Immunol. 1997 May;78(5):473-7
pubmed: 9164360
Allergy. 1994 Dec;49(10):894-6
pubmed: 7710003
Curr Opin Allergy Clin Immunol. 2002 Aug;2(4):341-6
pubmed: 12130949
J Allergy Clin Immunol. 1984 Mar;73(3):332-40
pubmed: 6699314
Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):337-41
pubmed: 17620826
J Allergy Clin Immunol. 2014 Jun;133(6):1635-43.e1
pubmed: 24365141
Allergy. 2005 Nov;60(11):1339-49
pubmed: 16197464
Clin Exp Allergy. 2003 Sep;33(9):1216-20
pubmed: 12956741
Allergol Immunopathol (Madr). 2006 Sep-Oct;34(5):180-4
pubmed: 17064646
J Allergy Clin Immunol. 2005 Mar;115(3):606-10
pubmed: 15753911
J Allergy Clin Immunol. 1985 May;75(5):556-62
pubmed: 3989140
Allergol Select. 2017 Aug 4;1(1):53-58
pubmed: 30402602
Clin Exp Allergy. 2021 Dec;51(12):1641-1644
pubmed: 34355432
Clin Exp Allergy. 2009 Oct;39(10):1467-76
pubmed: 19622088
Clin Exp Allergy. 1994 Nov;24(11):1010-5
pubmed: 7874599
Int Arch Allergy Immunol. 2009;148(3):261-4
pubmed: 18849617
Allergol Immunopathol (Madr). 1995 May-Jun;23(3):127-32
pubmed: 7572542
J Allergy Clin Immunol. 1982 Feb;69(2):200-7
pubmed: 7056951
J Allergy Clin Immunol. 2001 May;107(5):897-901
pubmed: 11344359
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3157-3163.e5
pubmed: 33962066
West J Med. 1999 Apr;170(4):223-7
pubmed: 10344177
Allergy. 2007 Aug;62(8):884-9
pubmed: 17620065
Ann Allergy Asthma Immunol. 1996 Nov;77(5):423-7
pubmed: 8933782
Allergy. 1995 Oct;50(10):800-5
pubmed: 8607561
Curr Opin Allergy Clin Immunol. 2005 Aug;5(4):343-7
pubmed: 15985817
J Allergy Clin Immunol. 1992 Sep;90(3 Pt 1):335-9
pubmed: 1345753
Allergy. 2008 Feb;63(2):226-32
pubmed: 18186813
Allergy. 1996 Jun;51(6):372-7
pubmed: 8837658
Allergy. 2011 Feb;66(2):222-8
pubmed: 20880144
Clin Allergy. 1978 May;8(3):259-65
pubmed: 668099
J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):151-9
pubmed: 8064067
Allergy. 2011 Oct;66(10):1395-6
pubmed: 21635267
Wien Klin Wochenschr. 2009;121(9-10):344-8
pubmed: 19562299
J Allergy Clin Immunol. 1996 Jul;98(1):39-47
pubmed: 8765816

Auteurs

Simona Perčič (S)

National Institute of Public Health, Centre for Environmental Health, Zaloška 29, 1000 Ljubljana, Slovenia.

Lidija Bojanić (L)

The University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik 36, 4204 Golnik, Slovenia.

Mitja Košnik (M)

The University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik 36, 4204 Golnik, Slovenia.
Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Zaloška 7, 1000 Ljubljana, Slovenia.

Andreja Kukec (A)

National Institute of Public Health, Centre for Environmental Health, Zaloška 29, 1000 Ljubljana, Slovenia.
Department of Public Health, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH